Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Clariant AG
  6. News
  7. Summary
    CLN   CH0012142631

CLARIANT AG

(CLN)
  Report
Delayed Quote. Delayed Swiss Exchange - 01/17 11:30:35 am
19.675 CHF   +0.72%
06:58aCLARIANT : JP Morgan reiterates its Neutral rating
MD
01:45aCLARIANT : Dr Achala Danait appointed as Managing Director, Clariant India…
PU
01/12CLARIANT : Test Headline N2
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Clariant : acquires remaining 70% in Brazilian Personal Care specialty company Beraca to seize full control

08/23/2021 | 01:00am EST

 

Clariant acquires remaining 70% in Brazilian Personal Care specialty company Beraca to seize full control

 

  • Personal Care business strengthened by assuming full operational ownership of Beraca’s broad portfolio of natural ingredients, supporting growing customer demand for sustainable and ethically sourced materials
  • Clariant to build on Beraca’s outstanding expertise in natural and organic certified ingredients sustainably drawn from Brazil’s biodiversity
  • Clariant to continue Beraca's contributions to Brazilian social and economic development of local communities


Muttenz/São Paulo, August 23, 2021Clariant, a focused, sustainable and innovative specialty chemicals company, has signed an agreement to acquire the remaining 70% in Brazilian Personal Care Specialties company Beraca from the founding Sabará family. Clariant has held a 30% stake in the company since 2015. The purchase price will not be disclosed. The acquisition is subject to regulatory approvals and is expected to close in Q4 2021.

Beraca is one of the key manufacturers of natural ingredients for the personal care sector offering inter alia fats, oils and botanicals, which are all collected and extracted in an environmentally sustainable production process. Located in the Amazon region, Beraca promotes the development of communities, making them part of the Personal Care business on a global scale while simultaneously being strongly committed to sustainability and fair trade processes. In more than 30 years since its foundation, Beraca has received several awards and recognition from customers and institutions as a leading company in ethical sourcing aspects for Personal Care ingredients. Since 2015, Beraca has invested significant resources in expanding research and innovation and has steadily increased production capacity. With around 90 employees, the family-run company generated sales of USD 15 million in 2020.

“With its focus on sustainable products and processes, Beraca fits perfectly into Clariant's portfolio,” emphasizes Conrad Keijzer, CEO of Clariant. “We gain valuable access to natural materials based on the biodiversity of the Brazilian rainforest. This opens up great opportunities for high-quality growth for our Care Chemicals business.” 

“There is an increasing demand for ethically produced products on the world market, which we can meet even better with this acquisition,” says Christian Vang, Head of Business Unit Industrial & Consumer Specialties. He welcomes the Beraca team: “The excellent and highly creative team has written an extraordinary success story over the past five years, which we now want to continue and further develop under the Clariant umbrella.”

The acquisition of the remaining 70% in Beraca is a relevant building block in the strategy of further strengthening individual core business areas through targeted acquisitions. Beraca’s business will be integrated into the Care Chemicals Business Area.

CORPORATE MEDIA RELATIONS INVESTOR RELATIONS
Jochen Dubiel

Phone +41 61 469 63 63
jochen.dubiel@clariant.com
andreas schwarzwälder

Phone +41 61 469 63 73
andreas.schwarzwaelder@clariant.com
Claudia Kamensky

Phone +41 61 469 63 63
claudia.kamensky@clariant.com
Maria Ivek

Phone +41 61 469 63 73
maria.ivek@clariant.com
  Alexander Kamb

Phone +41 61 469 63 73
alexander.kamb@clariant.com
Follow us on Twitter, Facebook, LinkedIn, Instagram.  
 

This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
www.clariant.com

 
Clariant is a focused, sustainable and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2020, the company employed a total workforce of 13 235. In the financial year 2020, Clariant recorded sales of CHF 3.860 billion for its continuing businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariant’s corporate strategy is based on five pillars: focus on innovation and R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.

Attachments

  • Clariant Media Release Clariant acquires remaining stake in Beraca 20210823 DE
  • Clariant Media Release Clariant acquires remaining stake in Beraca 20210823 EN

© OMX, source GlobeNewswire - EU Press Releases

All news about CLARIANT AG
06:58aCLARIANT : JP Morgan reiterates its Neutral rating
MD
01:45aCLARIANT : Dr Achala Danait appointed as Managing Director, Clariant India…
PU
01/12CLARIANT : Test Headline N2
PU
01/11CLARIANT : StyroMax® UL3 catalyst demonstrates outstanding…
PU
01/03Clariant Closes $876 Million Divestment of Pigments Business to Consortium
MT
01/03Clariant completes sale of its Pigments business
AQ
01/03Heubach GmbH, SK Capital Partners and Clariant AG completed the acquisition of Pigments..
CI
2021BASF India to Sell Manufacturing Site, Attapulgite Business in Florida to Clariant for ..
MT
2021EUROPE : 'Santa Rally' pushes European shares to five-week highs
RE
2021'Santa Rally' pushes European shares to five-week highs
RE
More news
Analyst Recommendations on CLARIANT AG
More recommendations
Financials
Sales 2021 4 302 M 4 709 M 4 709 M
Net income 2021 262 M 287 M 287 M
Net Debt 2021 1 164 M 1 274 M 1 274 M
P/E ratio 2021 24,9x
Yield 2021 2,46%
Capitalization 6 484 M 7 094 M 7 098 M
EV / Sales 2021 1,78x
EV / Sales 2022 1,56x
Nbr of Employees 13 057
Free-Float -
Chart CLARIANT AG
Duration : Period :
Clariant AG Technical Analysis Chart | CLN | CH0012142631 | MarketScreener
Technical analysis trends CLARIANT AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 19,68 CHF
Average target price 20,88 CHF
Spread / Average Target 6,11%
EPS Revisions
Managers and Directors
Conrad Keijzer Chief Executive Officer
Stephan Lynen Chief Financial Officer & Executive Vice President
Günter von Au Chairman
Hans Bohnen Chief Operating Officer & Executive Vice President
Eveline Saupper Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CLARIANT AG2.82%7 052
ECOLAB INC.-7.91%61 907
SIKA AG-13.05%51 797
GIVAUDAN SA-11.46%42 892
YUNNAN ENERGY NEW MATERIAL CO., LTD.10.42%36 079
EMS-CHEMIE HOLDING AG-6.12%24 558